Bright Minds Biosciences Inc. reported earnings results for the full year ended September 30, 2023. For the full year, the company reported net loss was CAD 7.37 million compared to CAD 14.96 million a year ago. Basic loss per share from continuing operations was CAD 1.98 compared to CAD 6.06 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.29 CAD | -0.77% | -21.82% | -39.15% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.15% | 4.22M | |
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |
- Stock Market
- Equities
- DRUG Stock
- News Bright Minds Biosciences Inc.
- Bright Minds Biosciences Inc. Reports Earnings Results for the Full Year Ended September 30, 2023